Indicators

Markets:

News

Cogent Biosciences, Inc. - Common Stock (NQ:COGT)

34.07 -0.67 (-1.93%)

Streaming Delayed Price Updated: 1:53 PM EDT, May 11, 2026 Add to My Watchlist

Price and Volume

Volume	424,709
Open	34.89
Bid (Size)	34.05 (300)
Ask (Size)	34.09 (200)
Prev. Close	34.74
Today's Range	34.03 - 35.01
52wk Range	4.550 - 43.73
Shares Outstanding	85,465,249
Dividend Yield	N/A

Chart for (: )

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

Cogent Biosciences Inc (NASDAQ:COGT) Shows Bullish Technical Breakout Setup with High Scores ↗

May 02, 2026

News headline image

The Great Rotation of 2026: Why Small Caps are Finally Dethroning the Tech Giants

March 27, 2026

The financial landscape of 2026 has been defined by a seismic shift in capital allocation that few analysts predicted with such intensity. For the first time in over a decade, the long-dormant Russell...

Via MarketMinute

Performance

YTD	-1.9%	-1.9%
1 Month	-6.3%	-6.3%
3 Month	-10.2%	-10.2%
6 Month	+5.0%	+5.0%
1 Year	+564.1%	+564.1%

More News

News headline image

The Great Rotation: Small-Caps Seize Market Leadership in Historic 2026 Breakout

March 25, 2026

Via MarketMinute

News headline image

This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch ↗

March 21, 2026

Via The Motley Fool

News headline image

High-Flying Biotech Stock Up 360% Faces $48 Million Trim but Remains This Fund's Largest Holding ↗

March 21, 2026

Via The Motley Fool

News headline image

This Fund Just Cut a Viridian Stock Position by Over $80 Million. Here's What Investors Should Know ↗

March 21, 2026

Via The Motley Fool

News headline image

This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know ↗

March 21, 2026

Via The Motley Fool

News headline image

Biotech Stock Up 72% Sees $8 Million Sale, but Here's Why One Fund Still Seems Bullish ↗

March 21, 2026

Via The Motley Fool

News headline image

Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026 ↗

March 20, 2026

Via The Motley Fool

News headline image

This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain ↗

March 18, 2026

Via The Motley Fool

News headline image

Sionna Stock Is Up 144% This Past Year. Is the Biotech a Buy as One Fund Makes a $7 Million Bet? ↗

March 18, 2026

Via The Motley Fool

News headline image

This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names ↗

March 18, 2026

Via The Motley Fool

News headline image

This Biotech Fund Sold $8 Million of Terns Stock Last Quarter, but Here's Why It Still Seems Very Bullish ↗

March 18, 2026

Via The Motley Fool

News headline image

This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision ↗

March 13, 2026

Via The Motley Fool

News headline image

Inside One Fund's $170 Million Bet on a Biotech Stock Up 1,040% in a Year Amid FDA Review for Breast Cancer Drug ↗

March 13, 2026

Via The Motley Fool

News headline image

Praxis Stock Has Surged 700% in a Year, and This Fund Is Betting $266 Million on Its Pipeline ↗

March 13, 2026

Via The Motley Fool

News headline image

Biotech Stock Up 365% as This $8 Million Investment Targets a Drug With 3 NDA Filings Planned ↗

March 13, 2026

Via The Motley Fool

News headline image

The Small-Cap Renaissance: Russell 2000 Eclipses Big Tech in Historic Early 2026 Surge

March 12, 2026

Via MarketMinute

News headline image

Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million ↗

February 17, 2026

Via The Motley Fool

News headline image

Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough ↗

February 17, 2026

Via The Motley Fool

News headline image

Large Biotech Fund Sells Shares of Cogent Biosciences for Over $120M ↗

February 01, 2026

Via The Motley Fool

News headline image

Cogent Insider Sells $2.5 Million in Stock Amid Staggering 300% Price Surge ↗

January 11, 2026

Via The Motley Fool

What's going on in today's after hours session ↗

December 30, 2025

News headline image

This Biotech Fund Just Made a $22 Million Bet on Pharvaris Stock — Is It a Buy? ↗

December 09, 2025

Via The Motley Fool

News headline image

Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow? ↗

December 09, 2025

Via The Motley Fool

Frequently Asked Questions

Is Cogent Biosciences, Inc. - Common Stock publicly traded?

Yes, Cogent Biosciences, Inc. - Common Stock is publicly traded.

What exchange does Cogent Biosciences, Inc. - Common Stock trade on?

Cogent Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Cogent Biosciences, Inc. - Common Stock?

The ticker symbol for Cogent Biosciences, Inc. - Common Stock is COGT on the Nasdaq Stock Market

What is the current price of Cogent Biosciences, Inc. - Common Stock?

The current price of Cogent Biosciences, Inc. - Common Stock is 34.07

When was Cogent Biosciences, Inc. - Common Stock last traded?

The last trade of Cogent Biosciences, Inc. - Common Stock was at 05/11/26 01:53 PM ET

What is the market capitalization of Cogent Biosciences, Inc. - Common Stock?

The market capitalization of Cogent Biosciences, Inc. - Common Stock is 2.91B

How many shares of Cogent Biosciences, Inc. - Common Stock are outstanding?

Cogent Biosciences, Inc. - Common Stock has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.